Bogdan Balas - Concepedia

Author

Bogdan Balas

The University of Texas Health Science Center at San Antonio ORCID

Also Known As

B Balas, B Balás, B. B. Balás, B. Balas, Balas B, Balas, Bogdan, Bogdan Balas, Bogdan Balas†, J. Westerbacka

Publications

4.7K

Citations

H-Index

Concepts

All Affiliations

The University of Texas Health Science Center at San Antonio Roche (Switzerland)University of California, Irvine National Research Council Gdańsk Medical University

About

Bogdan Balas is an author at The University of Texas Health Science Center at San Antonio specializing in medicine, metabolic syndrome, and health sciences.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	466
2	Health Sciences	4	4	341
3	Biochemistry	3	3	298
4	Cell Biology	2	2	159
5	Natural Sciences	1	1	63

Bogdan Balas

Publications

4.6K

Citations

H-Index

Page 1

	Year	Citations
A Placebo-Controlled Trial of Pioglitazone in Subjects with Nonalcoholic Steatohepatitis Renata Belfort, Stephen A. Harrison, Kenneth Brown, New England Journal of Medicine	2006	1.8K
Muscle and Liver Insulin Resistance Indexes Derived From the Oral Glucose Tolerance Test Muhammad Abdul-Ghani, Masafumi Matsuda, Bogdan Balas, Diabetes Care	2006	547
Alectinib versus chemotherapy in crizotinib-pretreated anaplastic lymphoma kinase (ALK)-positive non-small-cell lung cancer: results from the phase III ALUR study Silvia Novello, Julien Mazières, In‐Jae Oh, Annals of Oncology	2018	336
Alectinib versus crizotinib in treatment-naive anaplastic lymphoma kinase-positive (ALK+) non-small-cell lung cancer: CNS efficacy results from the ALEX study Shirish M. Gadgeel, Solange Peters, Tony Mok, Annals of Oncology	2018	319
Importance of Changes in Adipose Tissue Insulin Resistance to Histological Response During Thiazolidinedione Treatment of Patients with Nonalcoholic Steatohepatitis† Amalia Gastaldelli, Stephen A. Harrison, Renata Belfort-Aguilar, Hepatology	2009	281
The Dipeptidyl Peptidase IV Inhibitor Vildagliptin Suppresses Endogenous Glucose Production and Enhances Islet Function after Single-Dose Administration in Type 2 Diabetic Patients Bogdan Balas, Muhammad R. Baig, Catherine E. Watson, The Journal of Clinical Endocrinology & Metabolism	2007	242
Peripheral Disruption of the Grb10 Gene Enhances Insulin Signaling and Sensitivity In Vivo Lixin Wang, Bogdan Balas, Christine Y. Christ-Roberts, Molecular and Cellular Biology	2007	140
Deleterious action of FA metabolites on ATP synthesis: possible link between lipotoxicity, mitochondrial dysfunction, and insulin resistance Muhammad Abdul‐Ghani, Florian L. Müller, Yuhong Liu, American Journal of Physiology-Endocrinology and Metabolism Mitochondrial DysfunctionMitochondrial BiologyMetabolic RemodelingInsulin SignalingOxidative Stress	2008	139
Pioglitazone in the treatment of NASH: the role of adiponectin Amalia Gastaldelli, Stephen A. Harrison, R. Belfort‐Aguiar, Alimentary Pharmacology & Therapeutics	2010	114
The Fate of Taspoglutide, a Weekly GLP-1 Receptor Agonist, Versus Twice-Daily Exenatide for Type 2 Diabetes Julio Rosenstock, Bogdan Balas, B Charbonnel, Diabetes Care	2012	114

Page 1